Accium BioSciences and Quintiles Transnational Corporation Establish Strategic Partnership for Microdosing and Information-Rich(TM) Phase I Trials.SEATTLE -- Accium BioSciences, Inc., (Accium) the first fully-commercial Accelerator Mass Spectrometry accelerator mass spectrometry n. Mass spectroscopy in which a particle accelerator is used to disassociate molecules, ionize atoms, and accelerate the ions. (AMS AMS - Andrew Message System ) analytical facility in the U.S., and Quintiles Quintiles Transnational Corp. is a contract research organization which serves the pharmaceutical, biotechnology and healthcare industries. History Quintiles was founded in 1982 by Dennis Gillings and as of 2007 it has 18,000 employees. Transnational Corp., the world's leading pharmaceutical services company, today announced the establishment of a partnership to offer turnkey Exploratory-IND, Microdosing and Information-Rich(TM) Phase I clinical trials Noun 1. phase I clinical trial - a clinical trial on a few persons to determine the safety of a new drug or invasive medical device; for drugs, dosage or toxicity limits should be obtained phase I services to biopharmaceutical researchers. Accium's Accelerator Mass Spectrometer-based study design expertise and core bioanalytical capabilities combined with the clinical development and regulatory experience and expertise of Quintiles delivers a seamless solution to the critical decision process in early drug development. "This partnership leverages Accium's unique bioanalytical capabilities with the Quintiles' best practice clinical development processes to generate critical information very early in clinical development. By working together, we can now provide biopharmaceutical sponsors with a one-stop-shop solution for critical early phase drug trials," stated Michael Chansler, Vice President of Business Development for Accium. "Quintiles is recognized as the leader in pharmaceutical contract research. Establishing this partnership and successfully completing the stringent Quintiles quality audit ensures that our clients receive consistent, professional and timely clinical and bioanalytical services, whether they contract through Accium or Quintiles." Joseph Lacz, Ph.D., Vice President, Clinical Technology Services, Quintiles, said: "The FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. has issued the Exploratory IND guidance that gives the pharmaceutical industry new tools to conduct pharmacokinetics pharmacokinetics /phar·ma·co·ki·net·ics/ (fahr?mah-ko-ki-net´iks) the action of drugs in the body over a period of time, including the processes of absorption, distribution, localization in tissues, biotransformation, and excretion. (PK) and ADME ADME Absorption, Distribution, Metabolism, and Excretion ADME Association of Destination Management Executives ADME Active Duty Medical Extension (absorption, distribution, metabolism and excretion excretion, process of eliminating from an organism waste products of metabolism and other materials that are of no use. It is an essential process in all forms of life. In one-celled organisms wastes are discharged through the surface of the cell. ) trials earlier in the clinical development process. Quintiles is pleased to partner with Accium BioSciences to provide AMS-based bioanalytical capabilities supporting client requests for microdosing trials. Using these state-of-the-art trial designs and tools, pharmaceutical companies have the ability to select the best compound for further development earlier in the process. This allows an efficient use of their R&D budgets and a more rapid advancement of their new therapies." About Accium BioSciences Seattle-based Accium BioSciences (http://www.acciumbio.com) is the first company to fully commercialize Accelerator Mass Spectrometry (AMS) services in the U.S. with a focus on early drug development. Accium offers a full range of services for preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable. pre·clin·i·cal adj. 1. ADME testing, Exploratory IND/microdosing studies and Information-Rich(TM) Phase I clinical trials. Combining a state-of-the-art AMS analytical facility with a network of qualified and trusted partners, Accium offers a one-stop solution to enable earlier go/no-go decisions in the drug development process. About Quintiles Quintiles Transnational is the global leader in pharmaceutical services, improving healthcare worldwide by providing innovative, quality professional expertise, market intelligence and partnering solutions to meet the dynamic needs of the pharmaceutical, biotechnology and healthcare industries. Quintiles has 16,000 specialized employees and offices in 50 countries. For more information visit the company's Web site at www.quintiles.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion